Healthcare · Pharmaceutical expenditure

Pharmaceutical expenditure in Japan in 2026

Japan's pharmaceutical expenditure reached 2.30 % GDP of GDP in 2026, ranking 7th out of 197 countries. This high level is driven by the rapidly aging population — over 29% of Japanese are aged 65+ — and growing demand for prescription drugs, especially for chronic conditions. Japan hosts the world's third-largest pharmaceutical market, with giants like Takeda and Daiichi Sankyo leading innovation. High prices for patented drugs and widespread prescribing practices further elevate spending.

Data for 2026 · unit: % GDP
Position

Japan world ranking

#7 / 197

Country position on the scale from last to first place for this indicator.

JP
#7
#197#1
Trend

Change over time

Change in indicator over the available period.

1.50
1990
1.80
2000
2.00
2010
2.20
2020
2.30
2026

Values — % GDP

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Pharmaceutical expenditure in Japan — how much?
Based on 2026 data — 2.30 % GDP. This is rank #7 out of 197 countries.
What is Japan's rank by Pharmaceutical expenditure?
Japan ranks #7 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Japan?
Over the available period the indicator changed from 1.50 to 2.30 % GDP.